Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system - Evidence from event-related potentials

Experimental Neurology

Volumn 216, Issue 1, 2009, Pages 148-157

  Beste, Christian ^a,b   Konrad, Carsten ^c   Saft, Carsten ^d   Ukas, Tim ^c   Andrich, Jürgen ^d   Pfleiderer, Bettina ^c   Hausmann, Markus ^e   Falkenstein, Michael ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Frauenklinik   (Germany)

^e DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Event related potential (ERP); Huntington's disease; Voluntary movements

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; HUNTINGTON CHOREA; LEFT HEMISPHERE; MALE; MOTOR CONTROL; MOTOR CORTEX; NEUROMODULATION; PRIORITY JOURNAL; RESPONSE TIME; VOLUNTARY MOVEMENT;

ADULT; BRAIN; DOMINANCE, CEREBRAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MOTOR CORTEX; MOVEMENT; MOVEMENT DISORDERS; NEURAL INHIBITION; NEURAL PATHWAYS; REACTION TIME; VOLITION;

EID: 59749084715     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.11.018     Document Type: Article

References (59)

1. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Rosenblatt A., Brandt J., Gourley L.M., Liang K., Zhou H., Margolis R.L., and Ross C.A. Onset and rate of striatal atrophy in preclinical Huntington's disease. Neurology 62 (2004) 66-72
2. Ballanger B., Gil R., Audriffren M., and Desmurget M. Perceptual factors contribute to akinesia in Parkinson's disease. Exp. Brain Res. 179 (2007) 245-253
3. Beal M.F., and Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev., Neurosci. 5 (2004) 373-384
4. Berardelli A., Noth J., Thompson P.D., Bollen E.L., Curra A., Deuschl G., van Dijk J.G., Töpper R., Schwarz M., and Roos R.A. Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov. Disord. 14 (1999) 398-403
5. Bevan M.D., Magill P.J., Teman D., Bolam J.P., and Wilson C.J. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci. 25 (2002) 525-531
6. Beste C., Saft C., Yordanova J., Andrich J., Gold R., Falkenstein M., and Kolev V. unctional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease. Neuropsychologia 45 (2007) 2922-2930
7. Beste C., Saft C., Andrich J., Müller T., Gold R., and Falkenstein M. Time processing in Huntington's disease: a group-control study. PloS One 1 1 (2007) e1263
8. Beste C., Saft C., Konrad C., Andrich J., Habbel A., Schepers I., Jansen A., Pfleiderer B., and Falkenstein M. Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry. Hum. Brain Mapp. 29 (2008) 121-130
9. Blum D., Hourez R., Galas M.C., Popoli P., and Schiffmann S.N. Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. Lancet Neurol. 2 (2003) 366-374
10. Blumenfeld H., and McCormick D.A. Corticothalamic inputs control the pattern of activity generated in thalamocortical networks. J. Neurosci. 20 (2000) 5153-5162
11. Carbonell L., Hasbroucq T., Grapperon J., and Vidal F. Response selection and motor areas: a behavioural and electrophysiological study. Clin. Neurophysiol. 115 (2004) 2164-2174
12. Cepeda C., Wu N., Andre V.M., Cummings D.M., and Levine M.S. The corticostriatal pathway in Huntington's disease. Prog. Neurobiol. 81 (2007) 253-271
13. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp. Brain Res. 154 (2004) 1-10
14. Coles M.G., Gratton G., and Donchin E. Detecting early communication: using measures of movement-related potentials to illuminate human information processing. Biol. Psychol. 26 (1988) 69-89
15. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B., Roshan L., and Chen R. The mechanisms of Interhemispheric inhibition in the human motor cortex. J. Physiol. 543 (2002) 317-326
16. De Jong B.M., van der Graaf F.H., and Paans A.M. Brain activation related to the representations of external space and body scheme in visuomotor control. Neuroimage 14 (2001) 1128-1135
17. Di Lazzaro V., Pilato F., Dileone M., Tonali P.A., and Ziemann U. Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J. Physiol. 569 (2005) 315-323
18. Emri Z., Antal K., and Crunelli V. The impact of corticothalamic feedback on the output dynamics of a thalamocortical neurone model: the role of synapse location and metabotropic glutamate receptors. Neuroscience 117 (2003) 229-239
19. Feigin A., Ghilardi M.F., Huang C., Ma Y., Carbon M., Guttman M., Paulsen J.S., Ghez C.P., and Eidelberg D. Preclinical Huntington's disease: compensatory brain responses during learning. Ann. Neurol. 59 (2006) 53-59
20. Falkenstein M., Hohnsbein J., and Hoormann J. Effects of choice complexity on different subcomponents of the late positive complex of the event-related potential. Electroencephalogr. Clin. Neurophysiol. 92 (1994) 148-160
21. Ferbert A., Priori A., Rothwell J.C., Day B.L., Colebatch J.G., and Marsden C.D. Interhemispheric inhibition of the human motor cortex. J. Physiol. 453 (1992) 525-546
22. Ferre S., O'Connor W.T., Fuxe K., and Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13 (1993) 5402-5406
23. Finke K., Bublak P., Dose M., Müller H.J., and Schneider W.X. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. Brain 129 (2006) 1137-1151
24. Fisone G., Hakansson K., Borgkvist A., and Santini E. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiol. Behav. 92 (2007) 8-14
25. Gratton G., Coles M.G., and Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 55 (1983) 468-484
26. Gurney K., Prescott T.J., Wickens J.R., and Redgrave P. Computational models of the basal ganglia: from robots to membranes. Trends Neurosci. 27 (2004) 453-459
27. Hausmann M., Tegenthoff M., Sänger J., Janssen F., Güntürkün O., and Schwenkreis P. Transcallosal inhibition across the menstrual cycle: a TMS study. Clin. Neurophysiol. 117 (2006) 26-32
28. Jaffard M., Longcamp M., Velay J.-L., Anton J.-L., Roth M., Nazarian B., and Boulinguez. Proactive inhibitory control of movement assessed by event-related fMRI. NeuroImage (2008) [Electronic publication ahead of print]
29. Johnson K.A., Cunnington R., Bradshaw J.L., Chiu E., and Iansek R. Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease. Mov. Disord. 17 (2002) 998-1003
30. Johnson K.A., Cunnington R., Iansek R., Bradshaw J.L., Geargiou N., and Chiu E. Movement-related potentials in Huntington's disease: movement preparation and execution. Exp. Brain Res. 138 (2001) 492-499
31. Kassubek J., Juengling F.D., Ecker D., and Landwehrmeyer G.B. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb. Cortex 15 (2005) 846-853
32. Kendall A.L., Hantraye P., and Palfi S. Striatal tissue transplantation in non-human primates. Prog. Brain Res. 127 (2000) 381-404
33. Kremer B. Clinical neurology of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease (2002), Oxford University Press, Oxford 28-61
34. McDonnell M.N., Orekhov Y., and Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp. Brain Res. 173 (2006) 86-93
35. Melone M.A., Jori F.P., and Peluso G. Huntington's disease: new frontiers for molecular and cell therapy. Curr. Drug Targets 6 (2005) 43-56
36. Murer M.G., Tseng K.Y., Kasanetz F., Belluscio M., and Riquelme L.A. Brain oscillations, medium spiny neurons, and dopamine. Cell. Mol. Neurobiol. 22 (2002) 611-632
37. Nunez P.L., Srinivasan R., Westdorp A.F., Wijesinghe R.S., Tucker D.M., and Silberstein R.B. EEG coherency. I: statistics, reference electrode, volume conduction, Laplacians, cortical imaging, and interpretation at multiple scales. Electroencephalogr. Clin. Neurophysiol. 103 (1997) 499-515
38. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
39. Penney J.B., Young A.B., Shoulson I., Starosta-Rubenstein S., Snodgrass S.R., Sanchez-Ramos M., Ramos-Arroyo M., Gomez F., Penchaszadeh G., and Alvir J. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov. Disord. 5 (1990) 93-99
40. Praamstra P., Meyer A.S., Cools A.R., Horstink M.W., and Stegeman D.F. Movement preparation in Parkinson's disease. Time course and distribution of movement-related potentials in a movement precueing task. Brain 119 (1996) 1689-1704
41. Purves D. Modulation of Movement in the basal ganglia. In: Purves D., Augustine G.J., Fitzpatrick D., Hall W.C., LaMantia A.-S., McNamara J.O., and Williams S.M. (Eds). Neuroscience. 3rd edition (2004), Sinauer Associates, Sunderland Chapter 18
42. Roberts L.E., Rau H., Lutzenberger W., and Birbaumer N. Mapping P300 waves onto inhibition: Go/Nogo discrimination. Electroencephalogr. Clin. Neurophysiol. 92 (1994) 44-55
43. Roman R., Brazdil M., Jurak P., Rektor I., and Kukleta M. Intracerebral P3-like waveforms and the length of the stimulus-response interval in a visual oddball paradigm. Clin. Neurophysiol. 116 (2005) 160-171
44. Rosas H.D., Feigin A.S., and Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 1 (2004) 263-272
45. Seiss E., and Praamstra P. The basal ganglia and inhibitory mechanisms in response selection: evidence from subliminal priming of motor responses in Parkinson's disease. Brain 127 (2004) 330-339
46. Sommer M.A. The role of the thalamus in motor control. Curr. Opin. Neurobiol. 13 (2003) 663-670
47. Stahl J., and Gibbons H. The application of jackknife-based onset detection of lateralized readiness potential in correlative approaches. Psychophysiology 41 (2004) 845-860
48. Svenningsson P., Le Moine C., Fisone G., and Fredholm B.B. Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog. Neurobiol. 59 (1999) 355-396
49. Taniguchi Y., Burle B., Vidal F., and Bonnet M. Deficit motor cortical activity for simultaneous bimanual responses. Exp. Brain Res. 137 (2001) 259-268
50. Tarditi A., Camuri A., Varani K., Borea P.A., Woodman B., Bates G., Cattaneo E., and Abbracchio M.P. Early and transient alteration of adenosine A2A receptor signalling in a mouse model of Huntington's disease. Neurobiol. Dis. 23 (2006) 44-53
51. Thieben M.J., Dugins A.J., Good C.D., Gomes L., Mahant N., Richards F., McCusker E., and Frackowiak R.S. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125 (2002) 1815-1828
52. Ulrich R., and Miller J. Using the jackknife-based scoring method for measuring LRP onset effects in factorial designs. Psychophysiology 38 (2001) 816-827
53. Van Vugt J.P., van Hilten B.J., and Roos R.A. Hypokinesia in Huntington's disease. Mov. Disord. 11 (1996) 384-388
54. Van Vugt J.P., Piet K.K., Vink L.J., Siesling S., Zwinderman A.H., Middelkoop H.A., and Roos R.A. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. Mov. Disord. 19 (2004) 285-297
55. Verleger R. Event-related potentials and cognition: a critique of the context updating hypothesis and an alternative interpretation of P3. Behav. Brain. Sci. 11 (1988) 343-356
56. Verleger R., Jaskowski P., and Wascher E. Evidence for an Integrative role of P3b in linking reaction to perception. J. Psychophysiol. 19 (2005) 165-181
57. Wickens J.R., and Wilson C.J. Regulation of action-potential firing in spiny neurons of the rat neostriatum in vivo. J. Neurophysiol. 79 (1998) 2358-2364
58. Yohrling G.J., and Cha J.H. Neurochemistry of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease (2002), Oxford University Press, Oxford 276-308
59. Yordanova J., Kolev V., Hohnsbein J., and Falkenstein M. Sensorimotor slowing with ageing is mediated by a functional dysregulation of motor-generation processes: evidence from high-resolution event-related potentials. Brain 127 (2004) 351-362